|
|
||||||||
Ann Thorac Surg 2006;82:940-947
© 2006 The Society of Thoracic Surgeons
Center of Congenital Cardiac DiseaseSana Cardiac Surgical Clinic Stuttgart and Paediatric Cardiac Unit Olgahospital, Stuttgart, Germany
Accepted for publication April 24, 2006.
* Address correspondence to Dr Böhm, MD, Sana Herzchirurgische Klinik Stuttgart, Herdweg 2, D-70174 Stuttgart, Germany (Email: joboehm{at}z.zgs.de).
BACKGROUND: The Ross operation is increasingly accepted as an alternative to conventional valve prostheses for children, adolescents, and young adults. We review patients younger than 20 years of age.
METHODS: Of 404 Ross operations done before November 2004, 60 were young patients with a median age of 12 years (range, 1 to 20 years). The pulmonary autograft technique universally was as a free root. A cryopreserved pulmonary homograft reconstructed the right ventricular outflow tract.
RESULTS: Early postoperative complications were reentry for bleeding in 2 patients and one pacemaker insertion. No thromboembolic or hemorrhagic events occurred during the follow-up of 42 ± 27 months. Two late deaths occurred, one from myocardial infarction after 3 months and another sudden death after 5 years, probably from critical pulmonary homograft stenosis. Echocardiographic follow-up revealed a median peak gradient of 6.3 ± 3 mm Hg across the autograft. The median pulmonary homograft peak gradient of 19.1 ± 13.7 mm Hg was increased to more than 30 mm Hg in 6 patients. Another 6 patients had moderate but clinically insignificant pulmonary homograft regurgitation. Altogether, 6 patients required reoperation for replacement of stenotic homografts. No autograft related reoperation occurred.
CONCLUSIONS: Young patients with the Ross operation had good mid-term autograft function and no perioperative mortality. Factors that justify the choice of the Ross operation for young patients are the normal physiologic hemodynamics and growth of the autograft as well as freedom from anticoagulation. A 10% reoperation rate, elevated pulmonary homograft gradients, and the surgical complexity remain limiting factors.
This article has been cited by other articles:
![]() |
J. O. Bohm, W. Hemmer, J.-G. Rein, A. Horke, D. Roser, G. Blumenstock, and C. A. Botha A single-institution experience with the ross operation over 11 years. Ann. Thorac. Surg., February 1, 2009; 87(2): 514 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J.M. Takkenberg, L. M.A. Klieverik, P. H. Schoof, R.-J. van Suylen, L. A. van Herwerden, P. E. Zondervan, J. W. Roos-Hesselink, M. J.C. Eijkemans, M. H. Yacoub, and A. J.J.C. Bogers The Ross Procedure: A Systematic Review and Meta-Analysis Circulation, January 20, 2009; 119(2): 222 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Boethig, H. Goerler, M. Westhoff-Bleck, M. Ono, A. Daiber, A. Haverich, and T. Breymann Evaluation of 188 consecutive homografts implanted in pulmonary position after 20 years Eur. J. Cardiothorac. Surg., July 1, 2007; 32(1): 133 - 142. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sinzobahamvya, H. C. Blaschczok, B. Asfour, C. Arenz, M. J. Jussli, E. Schindler, J. Photiadis, and A. E. Urban Right ventricular outflow tract obstruction after arterial switch operation for the Taussig-Bing heart Eur. J. Cardiothorac. Surg., May 1, 2007; 31(5): 873 - 878. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |